Alantra-backed AIVORIQ acquires two Spanish dental labs
With the additions, the Alantra-backed platform now surpasses 20 laboratories and close to €40 million in revenue, adding capabilities in fixed prosthetics, aesthetic treatments and orthodontics for independent clinics.
The founders of two Spanish dental laboratories sold their businesses to AIVORIQ and reinvested in the Alantra Private Equity-backed platform, adding fixed prosthetics, aesthetic treatments and orthodontics capabilities that serve independent clinics.
The acquisitions lift the platform to more than 20 laboratories and close to €40 million in revenue, deepening its nationwide footprint in Spain.
“The evolution of AIVORIQ demonstrates the strength of our buy-and-build strategy in a fragmented and resilient healthcare market,” said Ángel Manotas, Managing Director at Alantra Private Equity.
Deal facts
- Target
- Two dental laboratories (unnamed)
- Acquirer
- AIVORIQ
- Backed by
- Alantra Private Equity
- Deal type
- Add-on
- Headquarters
- Spain
- Status
- Completed
- Announced
- Monday, June 15, 2026
Sources
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.